Please read this first. This guide is a companion to your medical team, not a replacement, and it is
not medical advice.
Everything here is tied to published research. If something you expected is not here, it almost always means we have not mapped a source for it yet,
not that it is unknown to medicine.
primary sclerosing cholangitis is an early, growing map, so it will look incomplete on purpose: we would rather show less and have every line be something you can check than fill the page with claims we cannot stand behind.
For anything about your own situation, your clinicians hold the full picture.
How this guide is built and why.
What's primary sclerosing cholangitis?
Primary sclerosing cholangitis is a chronic, progressive disease in which inflammation and fibrosis scar the bile ducts, producing multifocal strictures, chronic cholestasis, and over time cirrhosis. It is strongly associated with inflammatory bowel disease, especially ulcerative colitis, and carries an increased risk of cholangiocarcinoma. There is no established disease-modifying drug therapy; care centres on managing complications, endoscopic treatment of dominant strictures, and liver transplantation in advanced disease.
| Also indexed as | ORPHA:171, MONDO:0013433 |
| Features mapped | 14 |
| Treatments mapped | 2 |
| Published sources | 12 |
| Last reviewed | 2026-08-04 |
Signs and symptoms
Portal hypertension
As scarring stiffens the liver, blood backs up in the portal vein (portal hypertension), which can cause complications such as fluid build-up and bleeding.
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:37358638, ORPHA:171
Notesplain_language confirmed from PMID:37358638 via curation 2026-06-14. | regrounded primary ORPHA:171 -> PMID:41871593 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26
Fatigue
Primary sclerosing cholangitis is a long-term liver disease, and fatigue is one of the ways it can lower quality of life for people who have it.
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:36950480, PMID:42181857, ORPHA:171
Notesplain_language confirmed from PMID:36950480 via curation 2026-06-14. plain_language confirmed from PMID:42181857 via curation 2026-06-25 [claude-draft]. | regrounded primary ORPHA:171 -> PMID:41871593 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26
Pruritus
Itching, called pruritus, is a common symptom of primary sclerosing cholangitis and can greatly affect quality of life, disturbing sleep and worsening fatigue.
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:36950480, ORPHA:171
Notesplain_language confirmed from PMID:36950480 via curation 2026-06-14. plain_language confirmed from PMID:41678299 via curation 2026-06-25 [claude-draft]. | regrounded primary ORPHA:171 -> PMID:41678299 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26
Adenocarcinoma of the large intestine
When primary sclerosing cholangitis occurs together with inflammatory bowel disease, colorectal cancer is more common than in inflammatory bowel disease alone.
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41088845, ORPHA:171
Notesplain_language confirmed from PMID:41088845 via curation 2026-06-25 [claude-draft]. | regrounded primary ORPHA:171 -> PMID:41857231 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26
Cholangiocarcinoma
People with primary sclerosing cholangitis have a higher risk of cholangiocarcinoma, a cancer of the bile ducts, which is one reason a narrowed bile duct is examined carefully to tell inflammation apart from cancer.
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:40029142, PMID:40049717, ORPHA:171
Notesplain_language confirmed from PMID:40029142 via curation 2026-06-14. plain_language confirmed from PMID:40049717 via curation 2026-06-25 [claude-draft]. | regrounded primary ORPHA:171 -> PMID:41649752 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26
Elevated alkaline phosphatase of hepatic origin
A raised level of the liver enzyme alkaline phosphatase is a common marker of the blocked bile flow seen in primary sclerosing cholangitis, and a fall in this level can be a sign that the disease is responding.
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:36311961, PMID:37358638, ORPHA:171
Notesplain_language confirmed from PMID:36311961 via curation 2026-06-14. plain_language confirmed from PMID:37358638 via curation 2026-06-25 [claude-draft]. | regrounded primary ORPHA:171 -> PMID:42163804 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26
Abdominal pain
Many people with PSC have pain in the upper right side of the abdomen, where the liver and bile ducts sit. The pain often tracks with how blocked and inflamed the bile ducts are.
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:41571396, ORPHA:171
Notesplain_language confirmed from PMID:41571396 via curation 2026-06-18 [carrie (curation)]. | regrounded primary ORPHA:171 -> PMID:41871593 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26
Cholestasis
In primary sclerosing cholangitis, ongoing damage to the bile ducts blocks the normal flow of bile, a state called cholestasis. This buildup is a hallmark of the disease and drives many of its other features.
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:38976363, PMID:40655103, ORPHA:171
Notesplain_language confirmed from PMID:38976363 via curation 2026-06-14. plain_language confirmed from PMID:40655103 via curation 2026-06-25 [claude-draft]. | regrounded primary ORPHA:171 -> PMID:40049717 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26
Jaundice
Jaundice, a yellowing of the skin and eyes, develops when blocked bile ducts let bile pigments build up in the blood. It tends to appear as the disease advances.
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:37358638, ORPHA:171
Notesplain_language confirmed from PMID:37358638 via curation 2026-06-14. | regrounded primary ORPHA:171 -> PMID:41393988 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26
Abnormal biliary tract morphology
The hallmark of the disease is multiple narrowed, scarred segments of the bile ducts. On imaging such as MRCP this gives a characteristic beaded appearance that is central to the diagnosis.
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesORPHA:171
Notesplain_language confirmed from PMID:40049717 via curation 2026-06-14. | regrounded primary ORPHA:171 -> PMID:40049717 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26
Cirrhosis
Over time, the ongoing inflammation and scarring of the bile ducts in primary sclerosing cholangitis can lead to biliary cirrhosis, in which the liver becomes badly scarred and can eventually fail.
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42181857, PMID:41997818, ORPHA:171
Notesplain_language confirmed from PMID:42181857 via curation 2026-06-14. plain_language confirmed from PMID:41997818 via curation 2026-06-25 [claude-draft]. | regrounded primary ORPHA:171 -> PMID:41871593 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26
Hepatic fibrosis
PSC is driven by ongoing inflammation and scarring (fibrosis) of the bile ducts and surrounding liver. As the scarring builds up over years it can progress to cirrhosis and liver failure.
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:40029142, ORPHA:171
Notesplain_language confirmed from PMID:40029142 via curation 2026-06-18 [carrie (curation)]. | regrounded primary ORPHA:171 -> PMID:41871593 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26
Ulcerative colitis
Primary sclerosing cholangitis is closely linked to inflammatory bowel disease, and most people with it also have bowel inflammation such as ulcerative colitis.
Evidence ratingweak
Study designontology_import
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:42163467, PMID:42184528, ORPHA:171
Notesplain_language confirmed from PMID:42163467 via curation 2026-06-14. plain_language confirmed from PMID:42184528 via curation 2026-06-25 [claude-draft]. | regrounded primary ORPHA:171 -> PMID:42084721 on 2026-06-26 [Carrie Schluter, BCPA]
Last reviewed2026-06-26
Dominant biliary stricture
Primary sclerosing cholangitis can produce a dominant or high-grade narrowing of a bile duct that blocks bile flow; opening it with a balloon can drain the bile, ease symptoms, and help extend survival.
Evidence ratingweak
Study designcohort
Confidence (0-1)0.7
Replicationunreplicated
Supporting sourcesPMID:40049717
Notesplain_language confirmed from PMID:41223188 via curation 2026-06-18 [carrie (curation)]. plain_language revised from PMID:41223188 via curation 2026-06-18 [carrie (curation)]. plain_language confirmed from PMID:40049717 via curation 2026-06-25 [claude-draft].
Last reviewed2026-06-25
Treatment and management
What the research describes, not a recommendation. Treatment decisions belong with your clinician.
This covers treatments that appear in the published research mapped here. Investigational and experimental therapies are not included, so their absence is a boundary of this map, not a sign they do not exist.
liver transplantation
There is no medicine proven to change the course of primary sclerosing cholangitis. For advanced disease, liver transplantation is the only treatment that is definitive and prolongs life.
Used to help with: Primary sclerosing cholangitis.
The source text this rests on
“Increasing in incidence, PSC comprises a growing indication for liver transplantation (LT) with LT remaining the only proven life-prolonging therapy in patients with…”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:41997818 via curation 2026-06-25
Last reviewed2026-06-25
endoscopic balloon dilation of dominant stricture
When a single bile duct in primary sclerosing cholangitis becomes badly narrowed, doctors can widen it during an endoscopic procedure (ERCP) using a balloon to restore bile drainage and relieve symptoms.
Used to help with: Primary sclerosing cholangitis.
The source text this rests on
“ERCP is particularly important for patients who are not eligible for liver transplantation, as it allows bile drainage from the dominant or high-grade strictures through balloon…”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:40049717 via curation 2026-06-25
Last reviewed2026-06-25
What changes how it shows up
The diagnosis is not the whole story. The factors and open questions below are described in the research mapped here as shaping whether, or how strongly, the condition shows up, or as points the field has not yet settled. They are not, on their own, its cause or its cure.
inflammatory bowel disease association
Most people with primary sclerosing cholangitis also have inflammatory bowel disease. This combination behaves as a distinct pattern and raises the risk of colorectal cancer and of needing a liver transplant.
Described as modulating: Primary sclerosing cholangitis.
The source text this rests on
“Primary sclerosing cholangitis (PSC) is often intertwined with inflammatory bowel disease (IBD), presenting a complex clinical…”
An excerpt quoted verbatim from the source named above, shown as recorded. The full sentence is in the linked source.
Evidence ratingweak
Confidence (0-1)0.7
Replicationunreplicated
Notesconfirmed from PMID:41088845 via curation 2026-06-25
Last reviewed2026-06-25
How to read the evidence labels
Widely acceptedSpecialists broadly agree on this.
Strong evidenceBacked by solid, repeated research.
Moderate evidenceReasonable evidence, still being confirmed.
Limited evidenceSome evidence, but not yet convincing.
Early evidenceAn early finding that needs more study.
Experts disagreeResearchers actively disagree about this.
No longer supportedLater, stronger evidence or guidance overturned this.